Clinical Trial Detail

NCT ID NCT04310020
Title Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: senior adult

No variant requirements are available.